Search

everythinglearnresearchcommunity

for

Search:↓

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

PCOS may increase the risk of certain cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

New treatments for male hypogonadism are effective and should be personalized.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Spironolactone is effective and safe for treating hair loss, excessive hair growth, and acne.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

Early balding at 40 increases prostate cancer risk.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

The article suggests that the belief in common postpartum hair loss lacks sufficient evidence and may be overestimated.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Raspberry ketone lacks sufficient human research to support health benefit claims and requires more rigorous studies to confirm its safety and effectiveness.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Some vitamins and minerals like vitamin D and iron can help with certain types of hair loss, but more research is needed for others.

Smoking may contribute to hair loss in men.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.